A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The outcome for children with high-grade gliomas and diffuse intrinsic brainstem gliomas
remains poor despite the use of multi-modal therapy with surgery, radiation therapy and
chemotherapy.